Amgen Ebit from 2010 to 2026
| AMG Stock | EUR 329.30 11.55 3.63% |
EBIT | First Reported 2010-12-31 | Previous Quarter 14.9 B | Current Value 14.1 B | Quarterly Volatility 641.2 M |
Check Amgen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amgen's main balance sheet or income statement drivers, such as Tax Provision of 1.4 B, Interest Income of 218.9 M or Interest Expense of 1.7 B, as well as many indicators such as . Amgen financial statements analysis is a perfect complement when working with Amgen Valuation or Volatility modules.
Amgen | Ebit |
Evaluating Amgen's Ebit across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Amgen Inc's fundamental strength.
Latest Amgen's Ebit Growth Pattern
Below is the plot of the Ebit of Amgen Inc over the last few years. It is Amgen's EBIT historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Amgen's overall financial position and show how it may be relating to other accounts over time.
| Ebit | 10 Years Trend |
|
Ebit |
| Timeline |
Amgen Ebit Regression Statistics
| Arithmetic Mean | 12,944,148,235 | |
| Geometric Mean | 12,930,138,469 | |
| Coefficient Of Variation | 4.95 | |
| Mean Deviation | 396,880,277 | |
| Median | 12,856,000,000 | |
| Standard Deviation | 641,177,419 | |
| Sample Variance | 411108.5T | |
| Range | 2.4B | |
| R-Value | 0.74 | |
| Mean Square Error | 198930.9T | |
| R-Squared | 0.55 | |
| Significance | 0.0007 | |
| Slope | 93,852,353 | |
| Total Sum of Squares | 6577735.7T |
Amgen Ebit History
About Amgen Financial Statements
Amgen investors utilize fundamental indicators, such as Ebit, to predict how Amgen Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| EBIT | 14.9 B | 14.1 B | |
| EBITDA | 7.9 B | 8.6 B |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out the analysis of Amgen Correlation against competitors. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.